Pancreatic cancer is one of the deadliest of all cancers. Only 12% of men diagnosed with pancreatic cancer are alive five ...

New preclinical findings provide validation for Silexion’s new systemic administration approach for SIL-204, demonstrating ...

The findings suggest that "supportive care and management of geriatric vulnerabilities at baseline may improve outcomes and ...

With such volatility, SLXN has emerged as one of the most talked-about stocks of the day, creating a buzz in the biotechnology sector. Let’s dive into the details behind this remarkable movement and ...

Pancreatic Cancer Action Network Calls for Urgently Needed Research and Funding for Effective Early Detection Strategy and ...

Today the American Cancer Society called out the need for more progress on pancreatic cancer, citing it as the third-leading ...

Cancer diagnoses are expected to exceed two million in 2025, with approximately 618,120 deaths predicted, according to the ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

The new findings show the cancer mortality rate declined by 34% from 1991 to 2022 in the United States, averting ... Experimental Blood Test for Pancreatic Cancer Undergoing Clinical Development ...

Baseline geriatric vulnerabilities and QOL scores are associated with survival after chemotherapy in older adults with metastatic pancreatic cancer, researchers found.

Though cancer mortality overall is dropping, the burden of disease is shifting to women and younger adults, the American ...

Gastroenterologist Dr. Rohan Mandaliya of The Center for Comprehensive Pancreatic Care at Mercy goes over the risk factors of ...